Marco Mancini

6.7k total citations
125 papers, 4.1k citations indexed

About

Marco Mancini is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marco Mancini has authored 125 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Hematology, 48 papers in Genetics and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marco Mancini's work include Acute Myeloid Leukemia Research (58 papers), Chronic Myeloid Leukemia Treatments (54 papers) and Chronic Lymphocytic Leukemia Research (36 papers). Marco Mancini is often cited by papers focused on Acute Myeloid Leukemia Research (58 papers), Chronic Myeloid Leukemia Treatments (54 papers) and Chronic Lymphocytic Leukemia Research (36 papers). Marco Mancini collaborates with scholars based in Italy, United States and Germany. Marco Mancini's co-authors include Mauro Moresi, Daniela Diverio, Francesco Fazi, Clara Nervi, Franco Mandelli, Giuseppe Cimino, Rong Yang, Donnie McGrath, Giuliana Alimena and Cristina Mecucci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Marco Mancini

118 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Mancini Italy 32 1.8k 1.7k 714 692 651 125 4.1k
Mamatha M. Reddy United States 24 324 0.2× 765 0.5× 265 0.4× 99 0.1× 190 0.3× 72 2.0k
Edward L.G. Pryzdial Canada 24 656 0.4× 349 0.2× 176 0.2× 137 0.2× 195 0.3× 60 1.9k
Zaher K. Otrock Lebanon 26 1.1k 0.6× 770 0.5× 376 0.5× 136 0.2× 245 0.4× 116 3.0k
Duncan S. Pepper United Kingdom 37 1.5k 0.8× 980 0.6× 285 0.4× 58 0.1× 388 0.6× 128 4.1k
Nicole C. Walsh Australia 30 218 0.1× 1.8k 1.1× 107 0.1× 223 0.3× 356 0.5× 53 3.4k
D. Kay Blanchard United States 33 318 0.2× 619 0.4× 45 0.1× 84 0.1× 453 0.7× 68 4.2k
Akitada Ichinose Japan 37 2.5k 1.3× 719 0.4× 523 0.7× 59 0.1× 672 1.0× 159 4.7k
Ahnond Bunyaratvej Thailand 23 563 0.3× 277 0.2× 991 1.4× 356 0.5× 57 0.1× 61 1.9k
Grażyna Hoser Poland 26 509 0.3× 1.1k 0.7× 374 0.5× 188 0.3× 234 0.4× 125 2.5k
Jia Chen China 25 342 0.2× 494 0.3× 103 0.1× 158 0.2× 60 0.1× 163 2.1k

Countries citing papers authored by Marco Mancini

Since Specialization
Citations

This map shows the geographic impact of Marco Mancini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Mancini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Mancini more than expected).

Fields of papers citing papers by Marco Mancini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Mancini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Mancini. The network helps show where Marco Mancini may publish in the future.

Co-authorship network of co-authors of Marco Mancini

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Mancini. A scholar is included among the top collaborators of Marco Mancini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Mancini. Marco Mancini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carmosino, Ida, Massimo Breccia, Sara Mohamed, et al.. (2019). Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib. Oncology Research and Treatment. 42(12). 660–664. 3 indexed citations
2.
Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2018). Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?. European Journal Of Haematology. 101(5). 578–584. 1 indexed citations
3.
Baron, Frédéric, Marian Stevens‐Kroef, Michal Kiciński, et al.. (2018). Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype. Haematologica. 104(6). 1168–1175. 7 indexed citations
4.
Richetta, Antonio Giovanni, Paolo Curatolo, Marco Mancini, et al.. (2011). Efficacy of electrochemotherapy in ulcerated basal cell carcinoma.. PubMed. 162(5). 443–5. 4 indexed citations
5.
Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2010). “Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia. Leukemia Research. 34(11). 1472–1475. 35 indexed citations
6.
Fazi, Francesco, Serena Racanicchi, Giuseppe Zardo, et al.. (2007). Epigenetic Silencing of the Myelopoiesis Regulator microRNA-223 by the AML1/ETO Oncoprotein. Cancer Cell. 12(5). 457–466. 301 indexed citations
7.
Cimino, Giuseppe, Francesco Lo‐Coco, Susanna Fenu, et al.. (2006). Sequential Valproic Acid/All- trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia. Cancer Research. 66(17). 8903–8911. 102 indexed citations
8.
Alimena, Giuliana, Massimo Breccia, Roberto Latagliata, et al.. (2006). Sudden blast crisis in patients with Philadelphia chromosome‐positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy. Cancer. 107(5). 1008–1013. 18 indexed citations
9.
Gazzaruso, Carmine, Sebastiano Bruno Solerte, Emanuela Amici, et al.. (2005). Association of the Metabolic Syndrome and Insulin Resistance With Silent Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology. 97(2). 236–239. 34 indexed citations
10.
Breccia, Massimo, Ida Carmosino, Francesca Biondo, et al.. (2005). Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes. Leukemia Research. 30(2). 178–182. 13 indexed citations
11.
Specchia, Giorgina, Francesco Albano, Luisa Anelli, et al.. (2004). Insertions generating the 5′RUNX1/3′CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints. Genes Chromosomes and Cancer. 41(1). 86–91. 15 indexed citations
12.
Breccia, Massimo, Marco Mancini, Mauro Nanni, et al.. (2004). Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformation. Leukemia Research. 29(1). 33–39. 7 indexed citations
13.
Spirito, Francesca, Marco Mancini, Giuseppe Cimino, et al.. (2003). Trisomy 13 in a patient with common acute lymphoblastic leukemia: description of a case and review of the literature. Cancer Genetics and Cytogenetics. 144(1). 69–72. 6 indexed citations
14.
Mancini, Marco. (1997). Nochmals über oskisches sim. IRIS Research product catalog (Sapienza University of Rome). 110(1). 109–121. 3 indexed citations
15.
Alimena, Giuliana, Mario Lazzarino, Enrica Morra, et al.. (1996). Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferon.. IRIS Research product catalog (Sapienza University of Rome). 10(4). 615–8. 5 indexed citations
16.
Spiriti, Maria Antonietta Aloe, Maria Concetta Petti, Roberto Latagliata, et al.. (1993). Is Recombinant Human Erythropoietin Treatment in Myelodysplastic Syndromes Worthwhile?. Leukemia & lymphoma. 9(1-2). 79–83. 15 indexed citations
17.
Alimena, Giuliana, Giovanna Meloni, Francesco Lo‐Coco, et al.. (1993). Management of Chronic Myeloid Leukemia in Chronic Phase with Autologous Stem Cell Transplantation and Alpha-2 Interferon: Cytogenetic and Clinical Results. Leukemia & lymphoma. 11(sup1). 281–291. 4 indexed citations
18.
Alimena, Giuliana, Enrica Morra, Mario Lazzarino, et al.. (1991). IL TRATTAMENTO DELLA LEUCEMIA MIELOIDE CRONICA (LMC) CON INTERFERONE ∅-2B (IFN ∅2B). Haematologica. 76. 50. 1 indexed citations
19.
Alimena, Giuliana, et al.. (1989). Acute myeloblastic leukemia with t(8;21) following Philadelphia positive acute lymphoblastic leukemia.. PubMed. 3(4). 310–3. 9 indexed citations
20.
Fabritiis, Paolo de, G Meloni, F. Simone, et al.. (1988). High-dose chemotherapy and autologous stem cell infusion in patients with chronic myelogenous leukaemia in early phase of the disease. Bone Marrow Transplantation. 3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mamatha M. Reddy Breakdown of academic impact, for papers by Edward L.G. Pryzdial Breakdown of academic impact, for papers by Zaher K. Otrock Breakdown of academic impact, for papers by Duncan S. Pepper Breakdown of academic impact, for papers by Nicole C. Walsh Breakdown of academic impact, for papers by D. Kay Blanchard Breakdown of academic impact, for papers by Akitada Ichinose Breakdown of academic impact, for papers by Ahnond Bunyaratvej Breakdown of academic impact, for papers by Grażyna Hoser Breakdown of academic impact, for papers by Jia Chen
Rankless by CCL
2026